Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
08/2010
08/05/2010US20100197755 Hydrazone modulators of cannabinoid receptors
08/05/2010US20100197734 Pleuromutilin derivatives and their use as antimicrobials
08/05/2010US20100197725 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
08/05/2010US20100197708 Indole compounds
08/05/2010US20100197687 Indoles Useful in the Treatment of Inflammation
08/05/2010US20100197676 5-Substituted-2-Phenylamino Benzamides as Mek Inhibitors
08/05/2010US20100197673 Indole and indazole compounds as an inhibitor of cellular necrosis
08/05/2010US20100197657 2-aryl or heteroaryl indole derivatives
08/05/2010US20100196319 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
08/05/2010CA2750967A1 Sulfamoyl-phenyl-ureido benzamidine-derivatives as antimalarial agents
08/04/2010EP2213660A1 5-substituted indol-3-carboxylic acid derivatives exhibiting antiviral activity a method for the production and use thereof
08/04/2010EP2212286A1 Synthesis of quaternary salt compounds
08/04/2010EP2212285A1 N-acylhydrazone derivatives useful as modulators of nicotinic acetylcholine receptors
08/04/2010EP2212277A1 Amine linked modulators of y-secretase
08/04/2010EP2211855A1 Thrombopoietin receptor agonist (tpora) kills acute human myeloid leukemia cells
08/04/2010EP1756057B1 Process for the preparation of carvedilol
08/04/2010CN101796026A Guanidine-containing compounds useful as muscarinic receptor antagonists
08/04/2010CN101795727A Derivatives of 5-amino-4, 6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
08/04/2010CN101792450A spirocyclic 3-phenyl-3-substituted 4-ketolactams and 4-ketolactones
08/04/2010CN101792422A Novel organic electroluminescent compounds and organic electroluminescent device using the same
08/04/2010CN101792411A New method for combining ethyl sulfonamide
08/03/2010US7767672 Aminopyrimidines useful as kinase inhibitors
08/03/2010US7767194 Using cyanine dyes; in situ supplying to tumor cells
08/03/2010CA2598788C Indoline-sulfonamides compounds
08/03/2010CA2512926C Methods and compositions for inhibition of angiogenesis
08/03/2010CA2488052C Polymerization catalyst activators, method of preparing, and their use in polymerization processes
08/03/2010CA2306343C Novel aryloxy-alkyl-dialkylamines
07/2010
07/29/2010WO2010085820A2 Tricyclic compounds as antagonists of prostaglandin d2 receptors
07/29/2010WO2010085121A2 Novel organic compound, and an organic electronic device comprising the same
07/29/2010WO2010084852A1 Light-emitting element material and light-emitting element
07/29/2010WO2010083872A2 Materials for organic electroluminescence devices
07/29/2010WO2010039545A3 1,2-benzisothiazolinone and isoindolinone derivatives
07/29/2010WO2009157018A3 Novel polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
07/29/2010WO2009153457A3 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
07/29/2010US20100190998 Alcohols Containing Imide Moieties and Reactive Oligomers Prepared Therefrom
07/29/2010US20100190830 (3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-yl)-Acetic Acid Derivatives
07/29/2010US20100190826 Benzimidazole derivative
07/29/2010US20100190768 Novel fused pyrole derivative
07/29/2010US20100190764 Novel compounds
07/29/2010US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases
07/29/2010US20100190688 Tetrapeptide analogs
07/29/2010US20100189671 Indole amides as perfuming ingredients
07/29/2010US20100189648 Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
07/29/2010US20100189646 Carbazole Derivatives as Functional 5-HT6 Ligands
07/29/2010US20100188765 Oxime Ester Photoinitiators
07/29/2010US20100187978 Material for organic electro-optical device having fluorene derivative compound and organic electro-optical device including the same
07/29/2010US20100187508 Anthracene compounds for luminescent applications
07/29/2010US20100187505 Benzanthracene derivatives for organic electroluminescent devices
07/28/2010EP2209801A2 Manufacture, compositions and uses of coagulationfactor viia modulator
07/28/2010EP2209767A2 Production of monatin enantiomers
07/28/2010EP2209379A2 Production of monatin enantiomers
07/28/2010CN101790515A trans-3-aza-bicyclo[3.1.0]hexane derivatives
07/28/2010CN101790514A 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
07/28/2010CN101790513A 1,3-dihydroisoindole derivatives
07/28/2010CN101786981A Preparation method of 7(S)-Boc-amino-5-azaspiro [2,4] heptane
07/28/2010CN101786980A Synthesis method of isatin derivatives
07/28/2010CN101786978A 2-lactamine derivative
07/28/2010CN101786935A Method for extracting fluorene, anthracene and carbazole from mixed anthracene oil
07/27/2010US7763737 Carbazole compound, and polymer thereof
07/27/2010US7763645 Carvedilol dihydrogen phosphate monohydrate
07/27/2010CA2466560C Acetylene derivatives having mglur5 antagonistic activity
07/27/2010CA2445625C Pyrazino'1',2':1,6!pyrido'3,4-b!indole1,4-dione derivatives
07/22/2010WO2010083441A2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/22/2010WO2010082621A1 Organic electroluminescent element
07/22/2010WO2010082044A1 Unsaturated bicyclic heterocyclic derivatives as smo antagonists
07/22/2010WO2010065743A3 Bicyclic compounds and methods of making and using same
07/22/2010WO2010062927A3 Substituted octahydrocyclopnta (c) pyrrol-4 -amines as calcium channel blockers
07/22/2010WO2010041872A3 Novel compound and organic electronic device using same
07/22/2010US20100185419 Algorithm for designing irreversible inhibitors
07/22/2010US20100185014 Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts
07/22/2010US20100184977 Nickel or Iron Catalysed Carbon-Carbon Coupling Reaction of Arylenes, Alkenes and Alkines
07/22/2010US20100184975 Compounds for alzheimber's disease
07/22/2010US20100184942 Hybrid Host Materials For Electrophosphorescent Devices
07/22/2010US20100184768 Isoprenyl Compounds and Methods Thereof
07/22/2010US20100184762 Phthalimide derivatives that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
07/22/2010US20100183714 Gastroresistant pharmaceutical dosage form comprising n-(2-(2- phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)
07/22/2010US20100183712 Acylated indanyl amines and their use as pharmaceuticals
07/22/2010US20100183563 Dentinogenesis promoter and dentinogenic pulp-capping material
07/22/2010US20100181900 Carbazole compounds and organo-electroluminescent devices using the same
07/22/2010DE102009005289A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
07/22/2010DE102009005288A1 Materialien für organische Elektrolumineszenzvorrichtungen Materials for organic electroluminescent
07/22/2010CA2747835A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
07/21/2010EP2207768A1 Improved ramipril synthesis
07/21/2010EP1893573B1 Inhibitors of hcv replication
07/21/2010EP1399445B9 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
07/21/2010CN101784523A Novel compounds, compounds that influence cellular vesicular systems, pharmaceutical compositions, and use thereof
07/21/2010CN101781242A Method for preparing phthaloylamino acid
07/20/2010US7759499 used for the treatment or prevention of HCV or amelioration the symptoms of hepatitis C infection, by modulating the interaction of an HCV polypeptide with HCV proteases
07/20/2010US7759388 Phenylalanine derivatives
07/20/2010US7759387 such as (4-{2-[5-Carbamimidoyl-1-oxo-1,3-dihydro-isoindol-2-yl]-acetyl}-phenoxy)-acetic acid methyl ester, used for inhibiting the binding of fibrinogen to blood platelets, platelet aggregation and for the treatment of thrombotic diseases
07/20/2010US7759385 opioid receptor ligands such as {4-[3-(1H-indol-3-yl)-pyrrolidine-1-yl]-1-phenyl-cyclohexyl}-dimethylamine dihydrochloride salt, used as analgesics
07/20/2010US7759384 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
07/20/2010US7759366 4-[4,4-Dimethyl-2,5-dioxo-3-(2-phenylaminobenzyl)imidazolidin-1-yl]-2-trifluoromethylbenzonitrile, used for treating syndrome X, diabetes, obesity, drug abuse and dependence, schizophrenia, Alzheimer's disease, polycystic ovary syndrome and as dietetics
07/20/2010US7759313 Induction method for cell differentiation
07/20/2010US7759043 For resist applications; thermostability, storage stability; color filters
07/20/2010US7758972 Stilbene derivative, light emitting element, light emitting device, and electronic appliance
07/20/2010US7758861 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions
07/20/2010CA2486399C Calcium receptor modulating agents
07/20/2010CA2448798C Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1)
07/20/2010CA2424454C Cyanine dyes
1 ... 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 ... 458